• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effect of human proinsulin on blood glucose control and metabolic instability in type 1 diabetes mellitus.

作者信息

Bock E, Quabbe H J

机构信息

Department of Internal Medicine, Klinikum Steglitz, Freie Universität Berlin, FRG.

出版信息

Diabetes Res. 1989 Apr;10(4):165-9.

PMID:2692943
Abstract

UNLABELLED

The effect of human biosynthetic proinsulin (PRO) on blood glucose (BG) control and glucose excursions was studied in a nonrandomized design in eight patients with unstable type 1 diabetes mellitus and compared with that of human NPH insulin. Both preparations were injected subcutaneously twice daily for three days each in combination with small doses of regular insulin. All patients were kept in metabolic control during PRO treatment. Mean BG (mean of three days, 18 samples per day) was lower during PRO (mean +/- SE: 14.4 +/- 4.0 versus 11.4 +/- 3.0 mmol/l, p = 0.079). Inspection of individual data showed that four patients had similar BG profiles and mean daily BG concentrations with both preparations (12.3 +/- 1.1 vs 12.1 +/- 1.0 mmol/l), while the other four had significantly lower values during PRO (16.5 +/- 1.0 vs 10.1 +/- 1.1 mmol/l, p = 0.003). Metabolic instability (MAGE values) was similar during NPH and PRO (7.5 +/- 0.5 versus 7.0 +/- 0.5 mmol/l, H = 0.011, p = 0.88) when calculated for the entire group of patients. However, all patients with similar BG profiles during NPH and PRO treatment had smaller daily BG excursions on PRO (8.1 +/- 0.8 versus 6.6 +/- 0.6 mmol/l, p = 0.104, Wilcoxon test). The counterregulatory hormones, growth hormone and cortisol were not different between the two treatment periods or between the two groups. Plasma PRO concentrations (as determined through crossreaction in a C-peptide assay) did not correlate with the PRO dose (rxy = 0.508, p = 0.20), but correlated negatively with BG (rxy = 0.841, p = 0.009).

CONCLUSIONS

(1) Patients with type 1 mellitus can be kept in metabolic control during treatment with human PRO. (2) The dose of PRO considered equipotent to NPH insulin must be determined for each patient individually in order to avoid hypoglycemic attacks. (3) Although there was a tendency towards improved metabolic stability during PRO in some patients, this requires further investigations.

摘要

相似文献

1
Effect of human proinsulin on blood glucose control and metabolic instability in type 1 diabetes mellitus.
Diabetes Res. 1989 Apr;10(4):165-9.
2
Comparative study of hormonal counterregulation during GCIIS-guided hypoglycemia tests using human proinsulin and human insulin (recombinant DNA).使用人胰岛素原和人胰岛素(重组DNA)在葡萄糖钳夹技术诱导的低血糖测试期间激素对抗调节的比较研究
Horm Metab Res Suppl. 1988;18:24-33.
3
Investigation of the prolonged hypoglycemic effect of human proinsulin in diabetes mellitus.人胰岛素原在糖尿病中长效降糖作用的研究。
Horm Metab Res Suppl. 1988;18:12-5.
4
Substitution of basal delivery of insulin by proinsulin in type I diabetic patients under CSII.在持续皮下胰岛素输注(CSII)治疗下,I型糖尿病患者中用胰岛素原替代基础胰岛素输注。
Horm Metab Res Suppl. 1988;18:74-7.
5
Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart.1型糖尿病患者使用餐时门冬胰岛素时,每日两次甘精胰岛素与每日一次甘精胰岛素的比较。
Diabet Med. 2006 Aug;23(8):879-86. doi: 10.1111/j.1464-5491.2006.01913.x.
6
Blood glucose estimation and symptoms during hyperglycemia and hypoglycemia in patients with insulin-dependent diabetes mellitus.胰岛素依赖型糖尿病患者高血糖和低血糖期间的血糖估计及症状
Am J Med. 1995 Jan;98(1):22-31. doi: 10.1016/S0002-9343(99)80077-1.
7
Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.2型糖尿病患者在高血糖钳夹期间及之后β细胞对口服格列美脲给药的反应。
Diabet Med. 1997 Jul;14(7):556-63. doi: 10.1002/(SICI)1096-9136(199707)14:7<556::AID-DIA389>3.0.CO;2-6.
8
The impact of the timing of Humalog Mix25 injections on blood glucose fluctuations in the postprandial period in elderly patients with type 2 diabetes.优泌乐25注射时间对老年2型糖尿病患者餐后血糖波动的影响
Med Sci Monit. 2005 Dec;11(12):PI87-92. Epub 2005 Nov 24.
9
Treatment of type 1 diabetes with insulin lispro during Ramadan.斋月期间使用赖脯胰岛素治疗1型糖尿病。
Diabetes Metab. 2001 Sep;27(4 Pt 1):482-6.
10
Preprandial combination of lispro and NPH insulin improves overall blood glucose control in type 1 diabetic patients: a multicenter randomized crossover trial.赖脯胰岛素与中性鱼精蛋白锌胰岛素的餐时联合用药可改善1型糖尿病患者的整体血糖控制:一项多中心随机交叉试验。
Nutr Metab Cardiovasc Dis. 2001 Jun;11(3):168-75.